Hopital Edouard Herriot
Lyon, 69003, France
Location status: Recruiting
Location contact
Anne-Claire Lukaszewicz, PU-PH
CONTACT
NCT Number: NCT06073834
objective of LUNG-I3 study is to assess the quantitative and functional differences in cells between blood and bronchoalveolar lavage (BAL) fluid after an infection, with a special focus on alveolar macrophages and neutrophils
Interested in participating?
Request Info18 year and older
All sexes
Observational
Lyon, 69003, France
Location status: Recruiting
Anne-Claire Lukaszewicz, PU-PH
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All the following criteria
Exclusion criteria
Time frame: before and at time of VAP diagnosis
The primary endpoint will be to describe and compare the distribution of immune cells within the lung and the blood before VAP diagnosis (VAP prediction) and at the time of VAP diagnosis.
Contact information is provided by the study sponsor or research team.
Jean-François LLITJOS
CONTACT
Marie-Angelique CAZALIS
CONTACT
BioMérieux
Industry
LUNG INFECTION in ICU
Acronym: LUNG-I3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05952648
Cross Infection, Disease Attributes
Bologna, Italy
View Trial DetailsNCT06662630
Acute Respiratory Distress Syndrome, Atelectasis
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06045429
Cross Infection, Disease Attributes
Prague, Czechia
View Trial DetailsNCT06410664
Cross Infection, Disease Attributes
Prague, Česká Republika, Czechia
View Trial Details